Recursion Pharmaceuticals (NASDAQ:RXRX) outlined its strategy, clinical pipeline and partnership progress at Morgan Stanley’s ...

AI developers are striving for self-improvement, aiming for technology that can enhance itself. Concerns about AI escaping ...

September 11, 2026 16:26 ET Consumer prices data was the main news on the economic front in the U.S. this week. In Europe, ...

Outside the exhibit hall at Splunk .conf26 in Denver, Sunil Potti and I were talking about why he had come out of retirement.

Creation would no longer be only production. It would become a way of knowing. Another mind would be a mirror capable of ...

Argument about recursive self-improvement is loud, and very little of it is about evidence. It is about process. Everyone in ...

Introduction: Why Can Intelligence Improve Itself?When discussing AI, the term "recursive self-improvement" is sometimes used.Using one's own capabilities to improve oneself, and using those improved ...

Explore recursive self-improvement, agentic AI risks and the AI singularity debate, including OpenAI security incidents and ...

Georgia Tech researchers Zhiqi Li, Yuxuan Liao, and Bo Zhu introduce Recursive Code World Models (RCWM), a framework that reconstructs 3D worlds ...

Vitalik Buterin proposes recursive STARKs for Ethereum’s I-Star upgrade, aiming to cut computing costs and support new ...

Detailed price information for Recursion Pharmaceuticals Inc Cl A (RXRX-Q) from The Globe and Mail including charting and trades.

Recursion Pharmaceuticals, Inc. remains a Hold as competitive advances and slow revenue growth challenge its AI-driven drug discovery ambitions. RXRX's partnerships, notably with Genentech/Roche and ...